Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download

Trump's Q1 2026 trades show big bets on AI stocks and Bitcoin mining firm MARA.

Market News
15 May 2026
AMBCrypto
View Source
Bullish
pluang ai news

In Q1 2026, Donald Trump executed over 3,600 trades, holding large positions in AI-focused Nvidia and Bitcoin mining company MARA. His investments highlight a risk-on stance favoring tech and crypto infrastructure, with MARA representing Bitcoin mining amid tightening supply conditions. This suggests a long-term bullish view on Bitcoin, paralleling AI's growth story. Trump's portfolio reflects confidence in both AI and crypto sectors as key growth themes moving forward.

More News

AlphaPepe launches AlphaSwap Early Access enabling cross-chain trading before public launch.

AlphaPepe launches AlphaSwap Early Access enabling cross-chain trading before public launch.

AlphaPepe has introduced AlphaSwap Early Access, allowing users to trade selected pairs across Ethereum and Binance Smart Chain via Uniswap and PancakeSwap routers. This move provides a functional trading layer ahead of the official launch and positi...

Others
Bullish
53 minutes ago
Hamanasi Resort in Belize named #1 hotel in Central America and #15 worldwide by Tripadvisor in 2026.

Hamanasi Resort in Belize named #1 hotel in Central America and #15 worldwide by Tripadvisor in 2026.

Hamanasi Adventure & Dive Resort in Belize was ranked the #1 hotel in Central America and #15 globally in the 2026 Tripadvisor Travelers’ Choice Best of the Best Awards. This prestigious recognition is based on exceptional guest reviews and highlight...

Others
Neutral
1 hour ago
US government buys 10% stake in mining firms, signaling a new strategic investment trend.

US government buys 10% stake in mining firms, signaling a new strategic investment trend.

In early 2026, the US government began acquiring stakes in American mining companies, including a 10% share in USA Rare Earth to support critical mineral projects. This move follows similar investments in Lithium Americas and Trilogy Metals, which sa...

Market News
Bullish
1 hour ago
FDA approves Sanofi's Tzield as first disease-modifying therapy for stage 3 type 1 diabetes in children.

FDA approves Sanofi's Tzield as first disease-modifying therapy for stage 3 type 1 diabetes in children.

The FDA has granted accelerated approval to Sanofi's Tzield (teplizumab-mzwv) for children aged 8 to 17 recently diagnosed with stage 3 type 1 diabetes (T1D). This is the first disease-modifying therapy aimed at delaying the decline of insulin produc...

Market News
Bullish
3 hours ago
FDA approves Sanofi's Tzield as first disease-modifying therapy for newly diagnosed stage 3 type 1 diabetes in children.

FDA approves Sanofi's Tzield as first disease-modifying therapy for newly diagnosed stage 3 type 1 diabetes in children.

The FDA granted accelerated approval to Sanofi's Tzield (teplizumab-mzwv) for children aged 8 to 17 recently diagnosed with stage 3 type 1 diabetes (T1D). Tzield slows the decline of the body's insulin production by targeting the autoimmune process c...

Market News
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App